What is Sandu Pharmaceuticals share price return in the past 10 years?

Sandu Pharmaceuticals Ltd share price has appreciated 12.3% annually (CAGR) over the past ten years.

What is the P/E ratio of Sandu Pharmaceuticals?

The latest standalone P/E ratio of Sandu Pharmaceuticals as of 21-Nov-2024 is 36.63.

What is the P/B ratio of Sandu Pharmaceuticals?

The latest standalone P/B ratio of Sandu Pharmaceuticals as of 21-Nov-2024 is 1.36.

Sandu Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Sandu Pharmaceuticals
Brand: Sandu Pharmaceuticals

BSE: 524703 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Sandu Pharmaceutical Share Price

₹57.40 -0.12 -0.21%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Sandu Pharmaceutical

Based on:

Data

M-Cap below 100cr DeciZen not available

Sandu Pharmaceuticals stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

36.63

Market Cap:

55.6 Cr.

52-wk low:

52-wk high:

Is Sandu Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Sandu Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sandu Pharmaceuticals Ltd is a below average quality company.

2. Is Sandu Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Sandu Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Sandu Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sandu Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Sandu Pharmaceutical:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	6.8%	7.7%	5.3%	7.1%	7.6%	5.8%	7.9%	9.4%	6.9%	5.4%	-
Value Creation Index ⓘ	-0.5	-0.5	-0.6	-0.5	-0.5	-0.6	-0.4	-0.3	-0.5	-0.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	39.6	41.1	42.8	49	49.4	48.5	58.8	65.5	65.4	67.3	67
Sales YoY Gr.	-	3.7%	4.3%	14.5%	0.8%	-2%	21.3%	11.5%	-0.2%	3%	-
Adj EPS ⓘ	0.6	0.8	-0.7	0.7	1	1	1.4	1.8	1.6	1.5	1.6
YoY Gr.	-	31%	-194.7%	NA	28.4%	7.4%	35.3%	30.4%	-12.2%	-4.4%	-
BVPS (₹) ⓘ	25.6	26.4	25.1	26.2	27.4	28.2	29.6	30.7	40.6	42	42.2
Adj Net Profit ⓘ	0.4	0.5	-0.5	0.5	0.7	0.7	1.1	1.6	1.5	1.5	2
Cash Flow from Ops. ⓘ	4.8	-1.4	4.9	1.2	3.7	6.2	7.6	1	0.2	0.8	-
Debt/CF from Ops. ⓘ	2.6	-8	2.2	7.6	1.7	0.2	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	6.1%	6.4%	4.6%	3%
Adj EPS ⓘ	11.2%	9.7%	3.1%	-4.4%
BVPSⓘ	5.7%	8.9%	12.4%	3.5%
Share Price	12.3%	26.1%	6.8%	-14.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	2.3	2.9	-2.2	1.9	2.4	2.5	3.5	4.5	4	3.7	3.7
Op. Profit Mgn % ⓘ	6.2	7	4.3	5	4.2	3.2	3.7	4.4	3.8	3.4	3.5
Net Profit Mgn % ⓘ	1	1.3	-1.2	1.1	1.4	1.5	1.9	2.4	2.3	2.2	2.3
Debt to Equity ⓘ	0.7	0.6	0.6	0.5	0.3	0.1	0	0	0	0	-
Working Cap Days ⓘ	245	236	240	184	181	178	109	107	125	130	66
Cash Conv. Cycle ⓘ	112	87	104	101	104	96	50	46	49	58	36

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 3.70%

Sales growth has been subdued in last 3 years 4.62%

Net Profit has been subdued in last 3 years 3.05%

Sales growth is not so good in last 4 quarters at -0.05%

Latest Financials - Sandu Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	1.6	1.6
TTM Sales (₹ Cr.)	66.7	66.7
BVPS (₹.) ⓘ	42.2	42.2
Reserves (₹ Cr.) ⓘ	31	31
P/BV ⓘ	1.36	1.36
PE ⓘ	36.63	36.58

From the Market
52 Week Low / High (₹)	54.00 / 85.00
All Time Low / High (₹)	2.50 / 86.00
Market Cap (₹ Cr.)	55.6
Equity (₹ Cr.)	9.7
Face Value (₹)	10
Industry PE ⓘ	43

Management X-Ray of Sandu Pharmaceutical:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Sandu Pharmaceutical

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Sandu Pharmaceutical

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	39.60	41.08	42.83	49.02	49.42	48.45	58.76	65.50	65.35	67.28
Operating Expenses ⓘ	37.17	38.21	40.97	46.55	47.33	46.91	56.60	62.63	62.86	64.98
Manufacturing Costs	1.07	1.38	0.91	1.42	2.48	2.88	3.50	4.10	3.71	3.82
Material Costs	22.02	21.29	25.64	28.39	25.31	25.11	34.50	35.74	31.19	32.57
Employee Cost	3.69	4.51	5.42	5.94	6.49	6.85	8.02	8.91	11.10	10.07
Other Costs ⓘ	10.38	11.03	9.01	10.80	13.05	12.07	10.58	13.87	16.86	18.52
Operating Profit ⓘ	2.44	2.87	1.85	2.47	2.09	1.53	2.16	2.87	2.49	2.30
Operating Profit Margin (%)	6.1%	7.0%	4.3%	5.0%	4.2%	3.2%	3.7%	4.4%	3.8%	3.4%
Other Income ⓘ	0.14	0.15	0.47	0.12	0.57	0.38	0.19	0.08	0.33	0.42
Interest ⓘ	1.37	1.64	1.49	1.23	1.01	0.43	0.12	0.11	0.08	0.06
Depreciation ⓘ	0.57	0.69	0.87	0.60	0.64	0.55	0.56	0.53	0.52	0.58
Exceptional Items ⓘ	0	0	0.09	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.63	0.68	0.05	0.76	1.02	0.92	1.68	2.32	2.22	2.07
Tax ⓘ	0.22	0.14	0.50	0.19	0.35	0.20	0.59	0.73	0.70	0.61
Profit After Tax	0.41	0.54	-0.44	0.56	0.67	0.72	1.09	1.59	1.52	1.46
PAT Margin (%)	1.0%	1.3%	-1.0%	1.1%	1.4%	1.5%	1.9%	2.4%	2.3%	2.2%
Adjusted EPS (₹)	0.6	0.8	-0.6	0.8	0.9	1.0	1.4	1.8	1.6	1.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	36%	42%	48%	53%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	18.15	18.68	27.41	28.08	28.79	29.24	32.59	36.03	39.24	40.60
Share Capital ⓘ	7.08	7.08	7.08	7.08	7.08	7.08	7.92	8.81	9.66	9.66
Reserves ⓘ	11.06	11.60	20.33	21	21.71	22.16	24.67	27.22	29.58	30.93
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	11.88	10.83	10.02	9.35	6.10	1.25	0.02	0	0	0
Long Term Debt	1.19	0.78	0.09	0.25	0.18	0	0	0	0	0
Short Term Debt	10.68	10.05	9.93	9.11	5.93	1.25	0.02	0	0	0
Trade Payables	6.24	5.88	4.09	3.02	4.23	5.76	6.67	6.82	8.40	4.19
Others Liabilities ⓘ	5.25	6.02	4.92	4.07	4.51	5.17	7.68	6.43	6.52	7.63
Total Liabilities ⓘ	41.51	41.41	46.43	44.53	43.64	41.41	46.96	49.28	54.17	52.42
Fixed Assets
Gross Block	14.36	14.50	25.13	25.67	25.78	25.89	26.02	26.38	27.51	29.35
Accumulated Depreciation	6	6.69	7.64	8.10	8.73	9.29	9.84	10.37	10.89	11.47
Net Fixed Assetsⓘ	8.36	7.81	17.49	17.57	17.04	16.60	16.17	16	16.62	17.88
CWIP ⓘ	0	0	0	0	0	0	0	0.48	0.42	0
Investmentsⓘ	0.70	0.73	0.99	1.12	1.13	0.82	0.24	9.11	9.66	10.43
Inventories	12.68	12.04	10.68	11.44	13.26	14.36	11.14	11.27	14.33	12.25
Trade Receivables	6.56	7.15	6.35	6.69	4.80	4.68	5.35	3.99	4.79	4.87
Cash Equivalents	4.13	0.69	2.69	1.41	0.79	1.54	11.66	4.17	2.29	1.20
Others Assetsⓘ	9.09	12.98	8.24	6.29	6.62	3.40	2.41	4.26	6.07	5.79
Total Assets ⓘ	41.51	41.41	46.43	44.53	43.64	41.41	46.96	49.28	54.17	52.42

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	4.75	-1.43	4.91	1.23	3.74	6.20	7.59	0.95	0.22	0.76
PBT ⓘ	0.63	0.68	-0.04	0.76	1.02	0.92	1.68	2.32	2.22	2.07
Adjustment ⓘ	2.29	2.19	2.35	1.81	1.69	0.96	0.62	0.63	0.48	0.41
Changes in Working Capital ⓘ	1.96	-4.08	1.3	-1.01	1.35	4.47	5.75	-1.13	-1.78	-1.22
Tax Paid ⓘ	-0.13	-0.22	1.30	-0.32	-0.31	-0.14	-0.46	-0.88	-0.70	-0.50
Cash Flow From Investing Activity ⓘ	-0.18	0.05	-0.59	-0.62	-0.10	-0.37	-5.58	-5.47	0.53	-1.31
Capex	-0.32	-0.15	-0.61	-0.63	-0.11	-0.11	-0.13	-0.84	-1.07	-1.43
Net Investments	0	0.05	0	-0.01	0	-0.28	-5.64	-4.64	1.44	-0.04
Others ⓘ	0.14	0.15	0.02	0.03	0.01	0.02	0.19	0.01	0.16	0.16
Cash Flow From Financing Activityⓘ	-1.90	-2.06	-2.33	-1.89	-4.26	-5.36	1.30	0.93	0.58	-0.72
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	2.64	1.38	1.32	0
Net Proceeds from Borrowing ⓘ	-0.53	-0.42	-0.71	0.16	-0.06	-0.24	0	0	0	0
Interest Paid ⓘ	-1.37	-1.64	-1.49	-1.23	-1.01	-0.43	-0.11	-0.11	-0.08	-0.06
Dividend Paid ⓘ	0	0	0	0	0	0	0	-0.32	-0.66	-0.72
Others ⓘ	0	0	-0.12	-0.82	-3.18	-4.68	-1.23	-0.02	0	0.06
Net Cash Flow ⓘ	2.67	-3.44	1.99	-1.28	-0.62	0.48	3.31	-3.59	1.33	-1.27

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	2.28	2.92	-2.44	3.09	3.53	3.66	5.03	6.29	4.6	3.66
ROCE (%)	6.8	7.65	5.3	7.06	7.58	5.79	7.87	9.35	6.89	5.35
Asset Turnover Ratio	1.02	1.13	0.99	1.08	1.12	1.14	1.57	1.36	1.26	1.26
PAT to CFO Conversion(x)	11.59	-2.65	N/A	2.2	5.58	8.61	6.96	0.6	0.14	0.52
Working Capital Days
Receivable Days	57	53	56	48	42	36	26	26	25	26
Inventory Days	119	96	95	82	91	104	67	62	71	72
Payable Days	89	104	71	46	52	73	66	69	89	71

Sandu Pharmaceuticals Ltd Stock News

Sandu Pharmaceuticals Ltd FAQs

What is the share price of Sandu Pharmaceutical?

Company share prices are keep on changing according to the market conditions. The closing price of Sandu Pharmaceutical on 21-Nov-2024 16:59 is ₹57.40.

What is the market cap of Sandu Pharmaceutical?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Sandu Pharmaceutical stood at ₹55.57.

What is the P/E ratio of Sandu Pharmaceutical?

The latest P/E ratio of Sandu Pharmaceutical as of 21-Nov-2024 16:59 is 36.63.

What is the P/B ratio of Sandu Pharmaceutical?

The latest P/B ratio of Sandu Pharmaceutical as of 21-Nov-2024 16:59 is 1.36.

What is the 52-week high and low of Sandu Pharmaceutical?

The 52-week high of Sandu Pharmaceutical is ₹85.00 and the 52-week low is ₹54.00.

What is the TTM revenue of Sandu Pharmaceutical?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sandu Pharmaceutical is ₹66.68 ( Cr.) .

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.

The company is part of Sandu Group of Companies, which was established in the year in 1899. It is also developing bio-technology and has got encouraging results for the residual, waste products generated after extraction of green herbs, roots, etc.

The companyâ€™s state-of-the-art manufacturing unit is located at Plot No. 25, 26, 29 and 30, Pilerne Industrial Estate, Marra, Bardez, Goa 403511.

Sandu Pharmaceuticals has received ISO 9001-2000 certification for its quality management.

It has also commenced operations of its â€˜Sandu Ayurvedic Therapy Centreâ€™, which its plans to establish centres across India via franchisee business model.